Embed this press release by copying the code below:
Pluristem's Pivotal Phase III Critical Limb Ischemia Trial Approved by UK Regulatory Agency
Pluristem's Pivotal Phase III Critical Limb Ischemia Trial Approved by UK Regulatory Agency